Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer

Immunotherapy has been focused on by many oncologists and researchers. While, due to technical biases of absolute quantification, few traditional biomarkers for anti-PD-1 immunotherapy have been applied in regular clinical practice of non-small cell lung cancer (NSCLC). Therefore, there is an urgent...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chengming, Wang, Sihui, Zheng, Sufei, Xu, Fei, Cao, Zheng, Feng, Xiaoli, Wang, Yan, Xue, Qi, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640493/
https://www.ncbi.nlm.nih.gov/pubmed/34868057
http://dx.doi.org/10.3389/fimmu.2021.782106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640493/
https://www.ncbi.nlm.nih.gov/pubmed/34868057
http://dx.doi.org/10.3389/fimmu.2021.782106

Ejemplares similares